Safety and tolerability profile
Demonstrated safety profile1
Most common (≥15%) adverse reactions observed in PrTAVNEOS® patients
Please refer to the Product Monograph for a complete list of adverse reactions.
Reference:
1. TAVNEOS Product Monograph. Otsuka Canada Pharmaceutical Inc.